BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34907291)

  • 21. Interaction between the promoter
    Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
    Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Doubkova M; Kriegova E; Littnerova S; Schneiderova P; Sterclova M; Bartos V; Plackova M; Zurkova M; Bittenglova R; Lostaková V; Siskova L; Lisa P; Suldova H; Doubek M; Psikalova J; Snizek T; Musilova P; Vasakova M
    Ther Adv Respir Dis; 2021; 15():17534666211042529. PubMed ID: 34515605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival.
    Mota PC; Soares ML; Vasconcelos CD; Ferreira AC; Lima BA; Manduchi E; Moore JH; Melo N; Novais-Bastos H; Pereira JM; Guimarães S; Moura CS; Marques JA; Morais A
    J Mol Med (Berl); 2022 Sep; 100(9):1341-1353. PubMed ID: 35986225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.
    Fang C; Huang H; Feng Y; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
    Sci Rep; 2021 Jan; 11(1):1443. PubMed ID: 33446833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism.
    Chung JH; Peljto AL; Chawla A; Talbert JL; McKean DF; Rho BH; Fingerlin TE; Schwarz MI; Schwartz DA; Lynch DA
    Chest; 2016 May; 149(5):1215-22. PubMed ID: 26836909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.
    Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y
    PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
    Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
    Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A
    Verma A; Minnier J; Wan ES; Huffman JE; Gao L; Joseph J; Ho YL; Wu WC; Cho K; Gorman BR; Rajeevan N; Pyarajan S; Garcon H; Meigs JB; Sun YV; Reaven PD; McGeary JE; Suzuki A; Gelernter J; Lynch JA; Petersen JM; Zekavat SM; Natarajan P; Dalal S; Jhala DN; Arjomandi M; Gatsby E; Lynch KE; Bonomo RA; Freiberg M; Pathak GA; Zhou JJ; Donskey CJ; Madduri RK; Wells QS; Huang RDL; Polimanti R; Chang KM; Liao KP; Tsao PS; Wilson PWF; Hung AM; O'Donnell CJ; Gaziano JM; Hauger RL; Iyengar SK; Luoh SW;
    Am J Respir Crit Care Med; 2022 Nov; 206(10):1220-1229. PubMed ID: 35771531
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased frequency of angiotensin converting enzyme D allele in Chinese Han patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Wu X; Li W; Huang G; Luo Z; Chen Y
    Medicine (Baltimore); 2022 Oct; 101(40):e30942. PubMed ID: 36221416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries.
    Peljto AL; Selman M; Kim DS; Murphy E; Tucker L; Pardo A; Lee JS; Ji W; Schwarz MI; Yang IV; Schwartz DA; Fingerlin TE
    Chest; 2015 Feb; 147(2):460-464. PubMed ID: 25275363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
    Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
    Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
    Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
    Transpl Int; 2022; 35():10159. PubMed ID: 35651878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study.
    Manali ED; Kannengiesser C; Borie R; Ba I; Bouros D; Markopoulou A; Antoniou K; Kolilekas L; Papaioannou AI; Tzilas V; Tzouvelekis A; Daniil Z; Fouka E; Papakosta D; Xyfteri A; Karakatsani A; Loukides S; Korbila I; Tomos IP; Konstantinidis AK; Gogali A; Steiropoulos P; Papanikolaou IC; Bazaka C; Haritou A; Vassilakopoulos T; Maniati M; Kagouridis K; Markozannes E; Bouros E; Rampiadou C; Kounti G; Trachalaki A; Dimeas I; Karampitsakos T; Lyberopoulos P; Malamadakis N; Spyropoulou S; Revy P; Lainey E; Dieudé P; Rebah K; Ménard C; Oudin C; Masson C; Plessier A; Legendre M; Nathan N; Coulomb-L'Hermine A; Clement A; Amselem S; Boileau C; Crestani B; Papiris S;
    Respiration; 2022; 101(6):531-543. PubMed ID: 35078193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
    Oldham JM; Ma SF; Martinez FJ; Anstrom KJ; Raghu G; Schwartz DA; Valenzi E; Witt L; Lee C; Vij R; Huang Y; Strek ME; Noth I;
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1475-82. PubMed ID: 26331942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of MUC5B gene on antisynthetase syndrome.
    López-Mejías R; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Rozas SMF; Llorca J; Fernández DI; Cuesta VMM; Ortego-Centeno N; Gómez NP; Mera-Varela A; Martínez-Barrio J; López-Longo FJ; Mijares V; Lera-Gómez L; Usetti MP; Laporta R; Pérez V; Gafas AP; González MAA; Calvo-Alén J; Romero-Bueno F; Sanchez-Pernaute O; Nuno L; Bonilla G; Balsa A; Hernández-González F; Grafia I; Prieto-González S; Narvaez J; Trallero-Araguas E; Selva-O'Callaghan A; Gualillo O; Castañeda S; Cavagna L; Cifrian JM; González-Gay MA
    Sci Rep; 2020 Jan; 10(1):1415. PubMed ID: 31996780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
    Hobbs BD; Putman RK; Araki T; Nishino M; Gudmundsson G; Gudnason V; Eiriksdottir G; Zilhao Nogueira NR; Dupuis J; Xu H; O'Connor GT; Manichaikul A; Nguyen J; Podolanczuk AJ; Madahar P; Rotter JI; Lederer DJ; Barr RG; Rich SS; Ampleford EJ; Ortega VE; Peters SP; O'Neal WK; Newell JD; Bleecker ER; Meyers DA; Allen RJ; Oldham JM; Ma SF; Noth I; Jenkins RG; Maher TM; Hubbard RB; Wain LV; Fingerlin TE; Schwartz DA; Washko GR; Rosas IO; Silverman EK; Hatabu H; Cho MH; Hunninghake GM
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1402-1413. PubMed ID: 31339356
    [No Abstract]   [Full Text] [Related]  

  • 40. What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study.
    Reynolds CJ; Sisodia R; Barber C; Moffatt M; Minelli C; De Matteis S; Cherrie JW; Newman Taylor A; Cullinan P
    Occup Environ Med; 2023 Feb; 80(2):97-103. PubMed ID: 36635100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.